Michael N. Alonso

2.1k total citations · 1 hit paper
25 papers, 1.4k citations indexed

About

Michael N. Alonso is a scholar working on Immunology, Oncology and Epidemiology. According to data from OpenAlex, Michael N. Alonso has authored 25 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 6 papers in Oncology and 5 papers in Epidemiology. Recurrent topics in Michael N. Alonso's work include Immunotherapy and Immune Responses (12 papers), T-cell and B-cell Immunology (7 papers) and Immune Cell Function and Interaction (7 papers). Michael N. Alonso is often cited by papers focused on Immunotherapy and Immune Responses (12 papers), T-cell and B-cell Immunology (7 papers) and Immune Cell Function and Interaction (7 papers). Michael N. Alonso collaborates with scholars based in United States, Canada and Spain. Michael N. Alonso's co-authors include Edgar G. Engleman, Daniel A. Winer, Lei Shen, Matthew G. Davidson, Justin A. Kenkel, Hubert Tsui, Jason Yantha, Ping Wu, H.‐Michael Dosch and Geoffrey Paltser and has published in prestigious journals such as Nature Medicine, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Michael N. Alonso

23 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies

2011 806 citations Daniel A. Winer, Shawn Winer et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael N. Alonso United States	13	744	624	389	271	187	25	1.4k
Persis P. Wadia United States	11	514 0.7×	540 0.9×	317 0.8×	201 0.7×	50 0.3×	14	1.1k
Andrew P. R. Sutherland Australia	15	946 1.3×	241 0.4×	420 1.1×	357 1.3×	158 0.8×	20	1.9k
Benjamin Bondue Belgium	19	363 0.5×	519 0.8×	369 0.9×	283 1.0×	188 1.0×	60	1.7k
Gaetano Naselli Australia	20	590 0.8×	418 0.7×	352 0.9×	562 2.1×	160 0.9×	38	1.7k
Vijay Saxena United States	19	495 0.7×	425 0.7×	125 0.3×	278 1.0×	120 0.6×	39	1.5k
F.A. van de Loo Netherlands	20	517 0.7×	255 0.4×	163 0.4×	604 2.2×	280 1.5×	40	1.6k
Jean‐Denis Franssen Italy	9	668 0.9×	499 0.8×	277 0.7×	433 1.6×	211 1.1×	10	1.5k
Sébastien André France	17	404 0.5×	289 0.5×	255 0.7×	332 1.2×	88 0.5×	37	1.2k
Luis Zúñiga United States	10	660 0.9×	502 0.8×	282 0.7×	304 1.1×	236 1.3×	22	1.3k
Noriyoshi Ogawa Japan	23	532 0.7×	236 0.4×	694 1.8×	307 1.1×	237 1.3×	81	1.6k

Countries citing papers authored by Michael N. Alonso

Since Specialization

Citations

This map shows the geographic impact of Michael N. Alonso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael N. Alonso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael N. Alonso more than expected).

Fields of papers citing papers by Michael N. Alonso

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael N. Alonso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael N. Alonso. The network helps show where Michael N. Alonso may publish in the future.

Co-authorship network of co-authors of Michael N. Alonso

This figure shows the co-authorship network connecting the top 25 collaborators of Michael N. Alonso. A scholar is included among the top collaborators of Michael N. Alonso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael N. Alonso. Michael N. Alonso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pegram, Mark D., Carmen Calfa, Christopher S. Chen, et al.. (2024). Phase 2 study of novel HER2-targeting, TLR7/8 immune-stimulating antibody conjugate (ISAC) BDC-1001 (trastuzumab imbotolimod) +/- pertuzumab (P) in patients (pts) with HER2-positive metastatic breast cancer (MBC) previously treated with trastuzumab deruxtecan (T-DXd).. Journal of Clinical Oncology. 42(16_suppl). TPS1121–TPS1121. 1 indexed citations

Kenkel, Justin A., Po Y. Ho, Jason Ptacek, et al.. (2023). Abstract 2964: Targeting tumor-associated macrophages to enhance anti-tumor immunity with the Dectin-2 agonistic antibody BDC-3042. Cancer Research. 83(7_Supplement). 2964–2964. 1 indexed citations

Li, Bob T., Mark D. Pegram, Keun‐Wook Lee, et al.. (2023). A phase 1/2 study of a first-in-human immune-stimulating antibody conjugate (ISAC) BDC-1001 in patients with advanced HER2-expressing solid tumors.. Journal of Clinical Oncology. 41(16_suppl). 2538–2538. 34 indexed citations

Kenkel, Justin A., Po Y. Ho, Sameera Kongara, et al.. (2021). 862 Dectin-2, a novel target for tumor macrophage reprogramming in cancer immunotherapy. Regular and Young Investigator Award Abstracts. A903–A903.

Zhang, Xiangyue, Tyler R. Prestwood, Hong Zhang, et al.. (2020). Human Regulatory Dendritic Cells Develop From Monocytes in Response to Signals From Regulatory and Helper T Cells. Frontiers in Immunology. 11. 1982–1982. 17 indexed citations

Leblanc, Heidi, Cecelia I. Pearson, Justin A. Kenkel, et al.. (2020). 605 Systemically administered HER2-targeted ISACs provoke a rapid, local response that engages the innate and adaptive arms of the immune system to eradicate tumors in preclinical models. SHILAP Revista de lepidopterología. A361–A362. 5 indexed citations

Ackerman, Shelley E., Felix J. Hartmann, Cecelia I. Pearson, et al.. (2020). 603 Covalent attachment of a TLR7/8 agonist to tumor-targeting antibodies drives potent anti-tumor efficacy by synergistically activating FcgR- and TLR- signaling and enables safe systemic administration. SHILAP Revista de lepidopterología. A360.1–A360. 1 indexed citations

Ackerman, Shelley E., Joseph C. González, Josh Gregorio, et al.. (2019). Abstract 1559: TLR7/8 immune-stimulating antibody conjugates elicit robust myeloid activation leading to enhanced effector function and anti-tumor immunity in pre-clinical models. Immunology. 1559–1559. 2 indexed citations

Vallania, Francesco, Andrew Tam, Shane Lofgren, et al.. (2018). Leveraging heterogeneity across multiple datasets increases cell-mixture deconvolution accuracy and reduces biological and technical biases. Nature Communications. 9(1). 4735–4735. 100 indexed citations

10.

Carmi, Yaron, Tyler R. Prestwood, Matthew H. Spitzer, et al.. (2016). Akt and SHP-1 are DC-intrinsic checkpoints for tumor immunity. JCI Insight. 1(18). e89020–e89020. 20 indexed citations

11.

Chng, Melissa Hui Yen, Michael N. Alonso, Sarah E. Barnes, Khoa D. Nguyen, & Edgar G. Engleman. (2015). Adaptive Immunity and Antigen‐Specific Activation in Obesity‐Associated Insulin Resistance. Mediators of Inflammation. 2015(1). 593075–593075. 35 indexed citations

12.

Roedder, Silke, Li Li, Michael N. Alonso, et al.. (2014). A Three-Gene Assay for Monitoring Immune Quiescence in Kidney Transplantation. Journal of the American Society of Nephrology. 26(8). 2042–2053. 34 indexed citations

13.

Alonso, Michael N., et al.. (2014). Depletion of inflammatory dendritic cells with anti-CD209 conjugated to saporin toxin. Immunologic Research. 58(2-3). 374–377. 6 indexed citations

14.

Shen, Lei, Melissa Hui Yen Chng, Michael N. Alonso, et al.. (2014). B-1a Lymphocytes Attenuate Insulin Resistance. Diabetes. 64(2). 593–603. 83 indexed citations

15.

Davidson, Matthew G., Michael N. Alonso, Justin A. Kenkel, et al.. (2013). In Vivo T Cell Activation Induces the Formation of CD209+ PDL-2+ Dendritic Cells. PLoS ONE. 8(10). e76258–e76258. 6 indexed citations

16.

Davidson, Matthew G., Michael N. Alonso, Robert Yuan, et al.. (2013). Th17 Cells Induce Th1-Polarizing Monocyte-Derived Dendritic Cells. The Journal of Immunology. 191(3). 1175–1187. 22 indexed citations

17.

Junttila, Ilkka, Rémi J. Creusot, Ignacio Moraga, et al.. (2012). Redirecting cell-type specific cytokine responses with engineered interleukin-4 superkines. Nature Chemical Biology. 8(12). 990–998. 66 indexed citations

18.

Winer, Daniel A., Shawn Winer, Lei Shen, et al.. (2011). B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nature Medicine. 17(5). 610–617. 806 indexed citations breakdown →

19.

Wong, Michael T., Jessica Ye, Michael N. Alonso, et al.. (2010). Regulation of human Th9 differentiation by type I interferons and IL‐21. Immunology and Cell Biology. 88(6). 624–631. 100 indexed citations

20.

Garrote, José Antonio, et al.. (1995). Soluble CD4 antigen is increased in active coeliac disease.. PubMed. 371B. 1355–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact